These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 27454169)

  • 1. Cancer drug discovery: recent innovative approaches to tumor modeling.
    Lovitt CJ; Shelper TB; Avery VM
    Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D bioprinting for drug discovery and development in pharmaceutics.
    Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
    Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer drug discovery using multicellular tumor spheroid models.
    Zanoni M; Pignatta S; Arienti C; Bonafè M; Tesei A
    Expert Opin Drug Discov; 2019 Mar; 14(3):289-301. PubMed ID: 30689452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using 3D in vitro cell culture models in anti-cancer drug discovery.
    Langhans SA
    Expert Opin Drug Discov; 2021 Aug; 16(8):841-850. PubMed ID: 33823728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional in vitro cancer models: a short review.
    Wang C; Tang Z; Zhao Y; Yao R; Li L; Sun W
    Biofabrication; 2014 Jun; 6(2):022001. PubMed ID: 24727833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-bioprinted all-inclusive bioanalytical platforms for cell studies.
    Mazrouei R; Velasco V; Esfandyarpour R
    Sci Rep; 2020 Sep; 10(1):14669. PubMed ID: 32887912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging tumor spheroids technologies for 3D in vitro cancer modeling.
    Rodrigues T; Kundu B; Silva-Correia J; Kundu SC; Oliveira JM; Reis RL; Correlo VM
    Pharmacol Ther; 2018 Apr; 184():201-211. PubMed ID: 29097309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microfluidic technologies for anticancer drug studies.
    Valente KP; Khetani S; Kolahchi AR; Sanati-Nezhad A; Suleman A; Akbari M
    Drug Discov Today; 2017 Nov; 22(11):1654-1670. PubMed ID: 28684326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D cell culture systems modeling tumor growth determinants in cancer target discovery.
    Thoma CR; Zimmermann M; Agarkova I; Kelm JM; Krek W
    Adv Drug Deliv Rev; 2014 Apr; 69-70():29-41. PubMed ID: 24636868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro microbial culture models and their application in drug development.
    Vyawahare S; Zhang Q; Lau A; Austin RH
    Adv Drug Deliv Rev; 2014 Apr; 69-70():217-24. PubMed ID: 24566269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments with 3D bioprinting for novel drug discovery.
    Satpathy A; Datta P; Wu Y; Ayan B; Bayram E; Ozbolat IT
    Expert Opin Drug Discov; 2018 Dec; 13(12):1115-1129. PubMed ID: 30384781
    [No Abstract]   [Full Text] [Related]  

  • 14. High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.
    Martinez NJ; Titus SA; Wagner AK; Simeonov A
    Expert Opin Drug Discov; 2015 Dec; 10(12):1347-61. PubMed ID: 26394277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Culture Systems and 3D Interfaces Models for Cancer Drugs Testing.
    Fernandes DC; Canadas RF; Reis RL; Oliveira JM
    Adv Exp Med Biol; 2020; 1230():137-159. PubMed ID: 32285369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New experimental models of the blood-brain barrier for CNS drug discovery.
    Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
    Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
    Chwalek K; Bray LJ; Werner C
    Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfluidic 3D models of cancer.
    Sung KE; Beebe DJ
    Adv Drug Deliv Rev; 2014 Dec; 79-80():68-78. PubMed ID: 25017040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologically relevant in vitro tumor models for drug screening.
    Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
    Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring tumor response to anticancer drugs using stable three-dimensional culture in a recyclable microfluidic platform.
    Liu W; Xu J; Li T; Zhao L; Ma C; Shen S; Wang J
    Anal Chem; 2015 Oct; 87(19):9752-60. PubMed ID: 26337449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.